Ann: Investor Presentation, page-5

It would pay to keep in mind that the BOT management have strategically decided in their business plan to develop their products via the clinical process which means time - with a better chance of a massive payoff.

It is not a cosmetic. The market where every man and his dog puts a cream in a jar, fancy label and then adds a pack of lies with fancy marketing about turning your wrinkles into peaches and cream. Usually then repackaged under a different label with another celebrity to carry on the misleading story. Amusing really.

The products that BOT are producing are game changing in a market where the existing stakeholders have not had competition for years. "They" will be taking note as BOT are now well down the track with the relevant clinic trials - the business plan remains on track and much to unfold.